Intravitreal Injection of Ranibizumab and CTGF shRNA Improves Retinal Gene Expression and Microvessel Ultrastructure in a Rodent Model of Diabetes-Reference-Cited by-同舟云学术

Intravitreal Injection of Ranibizumab and CTGF shRNA Improves Retinal Gene Expression and Microvessel Ultrastructure in a Rodent Model of Diabetes

Published:2014-01-22 Issue:1 Volume:15 Page:1606-1624
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Hu Bojie,Zhang Yan,Zeng Qing,Han Qian,Zhang Lijuan,Liu Mian,Li Xiaorong

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/15/1/1606/pdf

Reference48 articles.

1. Diabetic retinopathy;Antonetti;N. Engl. J. Med,2012

2. Immunological mechanisms in the pathogenesis of diabetic retinopathy;Adamis;Semin. Immunopathol,2008

3. Pathomechanisms of cystoid macular edema;Bringmann;Ophthalmic Res,2004

4. Oxidative stress and diabetic retinopathy: Pathophysiological mechanisms and treatment perspectives;Madsen-Bouterse;Rev. Endocr. Metab. Disord,2008

5. Activation of protein kinase C isoforms and its impact on diabetic complications;Geraldes;Circ. Res,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-Related Macular Degeneration and its Current Treatment Strategies: An Updated Review;Macular Diseases - An Update;2024-02-09

2. A Nucleic Acid‐Based LYTAC Plus Platform to Simultaneously Mediate Disease‐Driven Protein Downregulation;Advanced Science;2024-01-22

3. Effect of Bone Marrow Mesenchymal Stem Cells on a Short-Term Induced Diabetic Retinopathy in Adult Female Albino Rats;Regenerative Engineering and Translational Medicine;2023-07-17

4. Blue light exposure collapses the inner blood-retinal barrier by accelerating endothelial CLDN5 degradation through the disturbance of GNAZ and the activation of ADAM17;Fluids and Barriers of the CNS;2023-04-24

5. Dynamin-like Protein 1 (DNML1) as a Molecular Target for Antibody-Based Immunotherapy to Treat Glaucoma;International Journal of Molecular Sciences;2022-11-07